31 Results for "

CCL17

" in MedChemExpress (MCE) Product Catalog:
Products (31)

31 Results for "CCL17" in MCE Product Catalog:

  • Recombinant Proteins Recommended:
1
1 Cited Publications
Cat. No.: HY-P71891A
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: C-C motif chemokine; CCL17
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P7759
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuCCL17, His; C-C motif chemokine 17; CC chemokine TARC; Small-inducible cytokine A17; Thymus and activation-regulated chemokine; CCL17; SCYA17; TARC
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-148494
CAS No.: 2174938-78-2
Purity:  99.85%
Synonyms: FLX475
Target:  

CCR

Research Areas:  

Inflammation/Immunology Cancer

Tivumecirnon (FLX475) is an orally active, selective CCR4 antagonist. Tivumecirnon blocks the binding of CCR4 to its ligands, CCL17 and CCL22, thereby reducing Treg infiltration into the tumor microenvironment. Tivumecirnon has antitumor activity .
loading...
    loading...
Cat. No.: HY-176949
CAS No.: 3092076-19-9
Target:  

STAT

Research Areas:  

Inflammation/Immunology

STAT6-IN-10 is a STAT6 (signal transducer and activator of transcription 6) inhibitor with an EC50 of 2 nM. STAT6-IN-10 can inhibit the secretion of CCL17 in human peripheral whole blood. STAT6-IN-10 can be used in the research of dermatological and respiratory system diseases .
loading...
    loading...
Cat. No.: HY-P3982
CAS No.: 960358-79-6
Target:  

CCR

Research Areas:  

Inflammation/Immunology

CKLF1-C19 is the C-terminal peptide of human chemokine-like factor 1 (CKLF1). CKLF1-C19 interacts with CCR4, and inhibits chemotaxis induced by both CKLF1 and CCL17. CKLF1-C19 can suppress allergic lung inflammation via inhibiting chemotaxis mediated by CCR3 and CCR4 .
loading...
    loading...
Cat. No.: HY-175650
CAS No.: 3092076-15-5
Research Areas:  

Inflammation/Immunology

STAT6-IN-9 is a potent STAT6 inhibitor with an EC50 value of 4 nM. STAT6-IN-9 effectively blocks STAT6 activation mediated by the IL-13-IL-13 receptor/IL-4 receptor pathway. STAT6-IN-9 inhibits CCL17 secretion with an IC50 value of 4.6 nM. STAT6-IN-9 can be used to investigate various chronic inflammatory diseases mediated by STAT6, such as allergy, asthma, and chronic obstructive pulmonary disease .
loading...
    loading...
Cat. No.: HY-174766
Target:  

mRNA

Research Areas:  

Inflammation/Immunology

Human CCL17 mRNA encodes the human C-C motif chemokine ligand 17 (CCL17) protein, a cytokine that displays chemotactic activity for T lymphocytes, but not monocytes or granulocytes. CCL17 plays important roles in T cell development in thymus as well as in trafficking and activation of mature T cells.
loading...
    loading...
Cat. No.: HY-RS02086
Research Areas:  

Others

CCL17 Human Pre-designed siRNA Set A contains three designed siRNAs for CCL17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS16826
Research Areas:  

Others

Ccl17 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ccl17 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS23268
Research Areas:  

Others

Ccl17 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ccl17 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P990982
CAS No.: 2922866-66-6
Synonyms: GSK3858279

Target:  

CCR

Research Areas:  

Inflammation/Immunology

HY-P990982 is an CCL17-targeting IgG2κ type human antibody, the recommed isotype control is Human IgG2 kappa, Isotype Control (HY-P99002) .
loading...
    loading...
Cat. No.: HY-185144
CAS No.: 3104330-39-1
Target:  

CCR

Research Areas:  

Inflammation/Immunology

CCL17-IN-1 (Compound Ex.132) is a CCL17 secretion inhibitor with an EC50 of 0.2 nM. CCL17-IN-1 can be used in the research of autoimmune diseases, dermatological conditions, and respiratory disorders .
loading...
    loading...
Cat. No.: HY-185145
CAS No.: 3104330-35-7
Target:  

CCR

Research Areas:  

Inflammation/Immunology

CCL17-IN-2 (Compound Ex.128) is a CCL17 secretion inhibitor with an EC50 of 0.3 nM. CCL17-IN-1 can be used in the research of autoimmune diseases, dermatological conditions, and respiratory disorders .
loading...
    loading...
Cat. No.: HY-P71902
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: C-C motif chemokine; CCL17
Species:  
Rat
Source:  
loading...
    loading...
Cat. No.: HY-P74532
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: C-C motif chemokine 17; CCL17; SCYA17; TARC
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P74531
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: C-C motif chemokine 17; CCL17; SCYA17; TARC
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P76667
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: C-C motif chemokine 17; CCL17; SCYA17; TARC
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P992378

Target:  

CCR STAT

Research Areas:  

Inflammation/Immunology Cancer

HZ-1127 is a thymic stromal lymphopoietin (TSLP) inhibitor. HZ-1127 selectively binds to TSLP, blocks receptor complex interaction, inhibits STAT5 activation, downstream inflammatory signaling, and TSLP-induced CCL17 and CCL22 secretion. HZ-1127 can be used for the research of allergic diseases and cancer .
loading...
    loading...
Cat. No.: HY-182564
CAS No.: 618865-88-6
Target:  

CCR

Research Areas:  

Cancer

ST45177901 is a CC chemokine receptor 4 (CCR4) antagonist. The combination of ST45177901 and Sorafenib (HY-10201) effectively inhibits the chemotaxis of Treg cells via the CCL22/CCL17-CCR4 signaling pathway, thereby significantly suppressing the growth and metastasis of tumor cells. ST45177901 is applicable to liver cancer research .
loading...
    loading...
Cat. No.: HY-119050
CAS No.: 749860-43-3
Target:  

CCR

Research Areas:  

Inflammation/Immunology

Anti-inflammatory agent 87 (compound 72) is a potential anti-inflammatory agent, whose precursor is an inhibitor targeting the binding of thymus and activation-regulated chemokine (TARC/CCL17) to Hut78 cells. Anti-inflammatory agent 87 can be used in the research of allergic diseases, autoimmune diseases, transplant rejection and other conditions .
loading...
    loading...